Molecular Pharming Market Expected to Grow at a CAGR of 7.46% from 2023-2031 | Latest InsightAce Survey


Companies covered in this report are Meristem Therapeutics S.A. (Ventria Bioscience),, Moolec Science Limited, Leaf Systems International Limite, Agrenvec S.L, Diamante SRL, ORF Genetics

Jersey City, NJ, April 11, 2023 (GLOBE NEWSWIRE) — The Global Molecular Pharming Market is estimated to exhibit a CAGR of 7.46% during the forecast period for 2023-2031.

Manufacturing recombinant medications using plant biotechnology is known as molecular pharming. By making highly efficient and cost-effective medications available to all facets of society, the technique has the potential to revolutionize the pharmaceutical industry. Expressing proteins in plants is more practical, secure, productive, and economical.


Molecular pharming refers to biologics production in plant systems to reduce the cost of microbial systems. The global molecular pharmaceutical industry will rise rapidly due to the expansion of studies into producing pharmaceuticals from plants and products. The sudden demand for precision medicine and its production from natural and organic sources will contribute to the market’s growth during the next five years.

Free PDF Report Brochure @

Additionally, the demand for molecular pharming is rising, propelling the global molecular pharming market’s growth in the next five years. This is because it is necessary to prioritize and identify the essential drugs to be accessible to the poor and financially unstable population. A recombinant technology that would make it possible to produce recombinant proteins like monoclonal.

Recent Developments:

  • In April 2022, Satellite Bio introduced a unique method for bioengineering tissues. This company has expertise in synthetic biology, regenerative medicine, cell therapy, cell biology, and tissue engineering.

List of Prominent Players in the Molecular Pharming Market:

  • Agrenvec S.L
  • Bright Biotech
  • Core Biogenesis
  • Diamante SRL
  • Leaf Systems International Limited
  • Medicago Inc
  • Meristem Therapeutics S.A. (Ventria Bioscience)
  • Miruku
  • Moolec Science Limited
  • mozza
  • Nobell Foods
  • ORF Genetics
  • Pfizer, Inc.
  • ProdiGene Inc
  • Protalix Biotherapeutics, Inc
  • Tiamat Sciences

Get Customized Report @

Molecular Pharming Market Report Scope:

Report Attribute Specifications
Growth rate CAGR CAGR of 7.46% from 2023 to 2031
Quantitative units Representation of revenue in US$ Billion, and CAGR from 2023 to 2031
Historic Year 2019 to 2022
Forecast Year 2023-2031
Report coverage The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends
Segments covered Crop Type, Technology, Applications And End Users
Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Market Dynamics:


Numerous partnerships have been formed between industry and non-industry groups to develop plant-based treatments. The global market for plant-based biologics is anticipated to expand at a healthy rate due to factors such as the rising prevalence of disease indications, rising demand for biologics, ongoing efforts to advance the development of such products, and further optimizing the related technologies.


Several issues, including depletion of natural resources and environmental degradation, restrict crop production. Furthermore, a lack of public awareness restricts the market’s growth.

Regional Trends:

The North American molecular pharming market is expected to register a considerable market share in revenue. It is projected to grow at a high CAGR shortly area is a pioneer in implementing new technologies. The region’s market has a high revenue due to factors including expanding government efforts that boost the implementation of modern agriculture technologies and established infrastructure. Besides, Asia Pacific has a substantial share in the molecular pharming market in emerging nations like India, Sri Lanka, and Nigeria. Numerous government projects are being carried out to promote contemporary precision agricultural technologies, increasing production.

Enquiry Before Buying @

Segmentation of Molecular Pharming Market-

Molecular Pharming Market, By Crop Source:

  • Maize
  • Barley
  • Tobacco
  • Safflower
  • Rice
  • Alfalfa

Molecular Pharming Market, By Technology:

  • Gene Gun
  • Agroinfiltration
  • Electroporation
  • Agrobacterium-Mediated Gene Transfer
  • Others

Molecular Pharming Market, By Application:

  • Recombinant Antibodies
  • Hormones
  • Vaccines
  • Industrial Enzymes
  • Proteins & Protein-Based Materials
  • Technical Reagents
  • Nutritional Products
  • Others

Molecular Pharming Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico


  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe


  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Check Discount on the Report @

About Us:

InsighAce Analytic is a specializing in market research and consulting services that helps in building business strategies. Our mission is to provide high quality insights with using data analytics techniques and visualization tools that drives the disruption and innovation in market research industry. Our expertise is in providing syndicated and custom market intelligence reports with in-depth analysis and key market insights in a timely and cost-effective manner.

Follow Us @

Subscribe Our Exclusive Newsletters @

CONTACT: Contact Us: InsightAce Analytic Pvt. Ltd. Tel.: +1 551 226 6109 Email: [email protected] Site Visit:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.